Third year student, Michael, in the DART research theme, submitted an abstract to the SCT Student Scholarship Committee and was selected as a finalist. He has been invited to present his paper "Do single-arm trials have a role in drug development plans incorporating randomised trials?" at the 37th Annual Meeting which will be taking place from the 15th - 18th May 2016, in Montreal, Quebec, Canada. The student judged to have the best paper will receive the Thomas C. Chalmers Student Scholarship prize and a $500 cash award.
His paper explores the appropriate usage of single-arm studies in phase II when a randomised two-arm trial will follow. Using a recently published non-small-cell lung cancer trial as an example, it discusses the efficiency of several possible drug development plans in order to detail how a clinician may determine the optimal design to use according to their prior beliefs.
This is a fantastic achievement for Michael. Michael says: "I am delighted to have been selected as a finalist and very grateful to the committee for having chosen me. With more and more novel treatments becoming available efficient phase II design is becoming increasingly important and I am excited to share our work on this topic in Montreal."